Timothy Moeller
Papers
1
Total Citations
6
H-Index
1
About
Timothy Moeller is a distinguished researcher in the field of in vitro toxicology and drug metabolism, with a focused expertise in cytochrome P450 (CYP) enzyme induction and hepatocyte-based assay development. His work addresses a critical challenge in pharmacology: predicting drug–drug interactions by understanding how xenobiotics affect CYP1A and CYP3A enzymes. Moeller’s most notable contribution is his pioneering development of automated, triplexed hepatocyte-based viability and CYP induction assays, which simultaneously measure cell health and enzyme activity. This innovation, detailed in his highly cited 2011 paper, streamlines the traditionally fragmented process of gathering toxicity and induction data, offering a more efficient and integrated approach for early-stage drug screening. By enabling high-throughput assessment of potential metabolic interactions, his research has provided pharmaceutical scientists with a powerful tool to identify problematic compounds earlier in development, thereby reducing late-stage failures. Though his citation count (6) reflects a specialized niche, the impact of his methodological advancement is significant within the toxicology community, where his work is recognized for enhancing the predictive accuracy and throughput of in vitro safety evaluations.
Research Focus
Key Achievements
Top Papers
- 1